Study on Using a New Fluorescent Imaging Technique for Prostate Cancer Diagnosis

Sponsor: Antelope Surgical Solutions, Inc

Sponsor score: 0
Inactive

ClinicalTrials ID:NCT06906471

Provider View

This clinical trial is testing a new fluorescent imaging method to help diagnose prostate cancer during standard biopsy procedures. The study aims to improve the accuracy of prostate cancer detection.

Patient Parameters

Program Overview

The purpose of this study is to evaluate a new fluorescent imaging technique, called AS1986NS, to see if it can help doctors better identify prostate cancer during a standard biopsy. This method uses a special fluorescent marker that targets PSMA, a protein often found in prostate cancer cells, to make them more visible under a microscope.

Eligibility Criteria

Inclusion Criteria

  • Men who are suspected of having prostate cancer and are scheduled for a standard multi-core prostate biopsy.

Exclusion Criteria

  • Patients receiving radiation therapy with Lutetium-177 or Actinium-225 on the same day.
  • Patients with existing liver, kidney, or heart problems, or those with a fever.
  • Patients with reduced kidney function, specifically a creatinine clearance below 60 mL/min.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.